James T. Borello RIA’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$312K Buy
1,192
+40
+3% +$10.3K 0.06% 92
2026
Q2
$290K Buy
1,152
+5
+0.4% +$1.08K 0.06% 95
2026
Q1
$249K Buy
1,147
+182
+19% +$40.4K 0.06% 94
2025
Q4
$220K Buy
965
+120
+14% +$27.3K 0.06% 94
2025
Q3
$196K Buy
845
+215
+34% +$43.8K 0.05% 96
2025
Q2
$117K Hold
630
– – 0.03% 108
2025
Q1
$132K Buy
630
+200
+47% +$38.9K 0.04% 90
2024
Q4
$76.4K Hold
430
– – 0.03% 103
2024
Q3
$84.9K Hold
430
– – 0.03% 91
2024
Q2
$73.8K Hold
430
– – 0.03% 90
2024
Q1
$78.3K Hold
430
– – 0.04% 89
2023
Q4
$66.6K Buy
+430
New +$62.7K 0.05% 65

Other funds holding ABBV

James T. Borello RIA's ABBV Position: Q3 2026 in Review

James T. Borello RIA increased its AbbVie (ABBV) stake by 3.5% in Q3 2026, buying an estimated $10.3K and bringing the position to 1,192 shares worth $312K. The position accounts for 0.06% of the portfolio, ranked #92.

James T. Borello RIA first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 1,352 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • James T. Borello RIA held 1,192 shares of AbbVie worth $312K as of Q3 2026.
  • James T. Borello RIA bought 40 AbbVie shares in Q3 2026, an estimated $10.3K.
  • AbbVie made up 0.06% of James T. Borello RIA's portfolio in Q3 2026, its #92 holding.
  • James T. Borello RIA first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 1,352 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.